Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

DTC Quantum names four Harwell cohort firms

3 min read
16:30UTC

Four quantum startups, £50k-£100k per cheque, 50 hours of business support each. A proof-of-concept gate rather than a runway.

← Back to Stryker agrees option to buy CMR SurgicalJump to analysis ↓
TechnologyDeveloping
Key takeaway

DTC Quantum stacks four UK startups across the quantum layers ProQure's £2bn was meant to commercialise.

UK Research and Innovation (UKRI), working through its Science and Technology Facilities Council (STFC) and the National Quantum Computing Centre (NQCC), named four startups in the DeepTech Catalyst Quantum (DTC Quantum) programme on 14 April 2026 at the Harwell campus: Curenetics (quantum and AI for cancer-vaccine targets), Coherence Engine (quantum control-system software), AmorphiQ (quantum and AI for materials degradation), and Qascade (light-based ultra-fast data movement). Each receives £50,000 to £100,000 in R&D funding plus 50 hours of business support and investor introductions.⁠1

DTC Quantum is the operating arm of the DeepTech Catalyst, founded in 2011 and now hosted at NQCC. The wider Catalyst has backed more than 230 startups, collectively raising over £300m in private follow-on and supporting roughly 1,100 jobs, with a claimed 95% company survival rate and a £25 return for every £1 of public money deployed. Quantum joined the programme as a dedicated vertical when the UK committed £2bn to quantum commercialisation via ProQure; DTC Quantum is the demand-side complement to ProQure's supply-side infrastructure.

The four selections map to the four layers of a working quantum stack: algorithms and applications (Curenetics, AmorphiQ), control software (Coherence Engine), and photonic interconnect (Qascade). That the UK can field one startup in each layer is the point; quantum commercialisation breaks if any rung is missing. None of the four has the capital to build at scale on £50k-£100k alone. The DTC money is a signal-and-support package designed to make them raisable, not a runway.

NQCC and STFC will be judged on the eighteen-month follow-on rate. If three of the four close private rounds above £2m by late 2027, ProQure has its commercial pipeline. If only one does, the vehicle gap between DTC tickets and ProQure's commercialisation infrastructure becomes the next policy fight. The ratio will matter more than the cohort itself.

Deep Analysis

In plain English

Quantum computers use the strange rules of physics at the atomic scale to solve certain types of problem much faster than normal computers. Four UK startups just received up to £100,000 each and introductions to investors to develop their quantum technologies. The amounts are small; roughly what a startup might spend on six months of salary; but the programme also gives them access to the Harwell science campus near Oxford, which has specialised lab equipment worth tens of millions that they could not afford to rent commercially. The government put £2bn into quantum infrastructure last year, and these four firms are the first startups meant to fill the commercial layer underneath that infrastructure.

Deep Analysis
Root Causes

The UK's £2bn ProQure commitment created a downstream procurement pipeline that justifies early-stage quantum investment in a way that had not previously existed; the DTC Quantum cohort is explicitly designed to populate the supply side of that pipeline with UK-owned companies before foreign quantum firms (IBM, IonQ, Quantinuum) capture the procurement contracts by default.

Quantum computing's interdisciplinary nature; requiring expertise in physics, materials science, software engineering, and systems integration simultaneously; means that the Harwell Science and Innovation Campus's co-location of neutron sources, electron microscopes, and high-field magnets provides infrastructure that no private incubator can replicate at comparable cost per company.

What could happen next?
  • Consequence

    If fewer than two of the four DTC Quantum cohort companies raise private follow-on rounds within 18 months, UKRI will face pressure from the Science and Technology Committee to justify the ProQure procurement pipeline against a weak commercial supply base.

  • Opportunity

    Qascade's light-based data movement technology is directly relevant to the AI data centre latency problem identified by the Slough saturation event (event-08); cross-programme contact between DTC Quantum and SAIU cohort companies at Harwell and London could accelerate deployment into UK AI infrastructure faster than standalone commercial timelines.

Sources:UKRI / STFC·UKRI / STFC
Mentions:Science and Technology Facilities Council →National Quantum Computing Centre →DeepTech Catalyst Quantum →AmorphiQ →Qascade →Coherence Engine →Curenetics →Cambridge →Innovate UK →UKRI →ProQure →Cohere →Velocity →Quantum computing →
First Reported In

Update #2 · Britain's innovation pipe leaks at both ends

UKRI / STFC· 22 Apr 2026
Read original →
Causes and effects
Caused by
UK commits £2bn to quantum deployment
The DTC Quantum cohort at Harwell is the commercial startup layer the ProQure £2bn quantum commitment (ID:2349) was intended to catalyse.
Occurred 1 Mar 2026
Read story →
This Event
DTC Quantum names four Harwell cohort firms
The DTC Quantum cohort is the commercial startup layer the UK's £2bn ProQure commitment was designed to catalyse; its eighteen-month follow-on rate will be the first test of whether the money has reached deal-ready companies.
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.